News

The Alzheimer's Association® will present 10 scientific awards at the Alzheimer's Association International Conference® 2025 (AAIC®), recognizing researchers for their expertise, noteworthy ...
In a Phase Ib/IIa trial, 91% of patients receiving the highest dose of trontinemab were amyloid negative after seven months ...
Key Takeaways At AAIC 2025, the Alzheimer's Association released the first in a series of clinical practice guidelines for the diagnosis, treatment and care of Alzheimer's and all other ...
Although it's not always easy to determine if an individual can make decisions, a judge understands the obvious that a ...
Microglia, a type of brain immune cell, can gobble up amyloid beta protein, which clumps together into toxic aggregates ...
Scientists at UCSF have uncovered how certain immune cells in the brain, called microglia, can effectively digest toxic ...
ALZpath’s pTau217 antibody is drawing significant attention at this year’s Alzheimer's Association International Conference (AAIC), taking place in Toronto, Canada, from 27-31 July. The biomarker ...
Researchers say the repurposed drugs could accelerate a long-stalled path toward meaningful Alzheimer’s treatment. (Scripps News) ...
The Columbus Alzheimer’s/Dementia Support Group will meet at 1:30 p.m. Monday, July 28, at the Columbus Senior Center (old ...
In Alzheimer's disease, proteins like amyloid beta form clumps, known as plaques, that damage the brain.But in some people, ...
Massive proteomics database links gene variant APOE 4 to chronic inflammation.
The opinion will now be referred to the European Commission for final regulatory decision on donanemab  INDIANAPOLIS, July 25 ...